S-Clinica

Executive Summary

S-Clinica, headquartered in Leuven, Belgium, is a digital health and AI company specializing in advanced supply management algorithms for clinical trials. Founded and owned by clinical trial experts, biostatisticians, and mathematicians, the company leverages over 27 years of industry expertise to deliver predictive probabilistic algorithms that adjust in real-time, offering what it claims is the industry’s most advanced and comprehensive solution. By optimizing trial supply chains, S-Clinica aims to reduce waste, ensure medication availability, and improve trial efficiency for pharmaceutical sponsors and contract research organizations. Despite its specialized niche and depth of experience, the company remains private with limited public financial or funding information, suggesting it may be in a growth or early commercial stage. The growing demand for decentralized and efficient clinical trials, coupled with increasing regulatory pressures for supply chain transparency, positions S-Clinica’s algorithm as a potentially valuable tool for improving trial outcomes and reducing costs.

Upcoming Catalysts (preview)

• Q3 2026Partnership with a top-10 pharmaceutical company for algorithm implementation40% success
• Q4 2026Regulatory endorsement or qualification from EMA or FDA for supply management algorithm30% success
• Q2 2027Series A funding round to scale commercialization and expand team60% success